| Literature DB >> 24218580 |
Bin Gong1, Thomas Shelite, Fang C Mei, Tuha Ha, Yaohua Hu, Guang Xu, Qing Chang, Maki Wakamiya, Thomas G Ksiazek, Paul J Boor, Donald H Bouyer, Vsevolod L Popov, Ju Chen, David H Walker, Xiaodong Cheng.
Abstract
Rickettsiae are responsible for some of the most devastating human infections. A high infectivity and severe illness after inhalation make some rickettsiae bioterrorism threats. We report that deletion of the exchange protein directly activated by cAMP (Epac) gene, Epac1, in mice protects them from an ordinarily lethal dose of rickettsiae. Inhibition of Epac1 suppresses bacterial adhesion and invasion. Most importantly, pharmacological inhibition of Epac1 in vivo using an Epac-specific small-molecule inhibitor, ESI-09, completely recapitulates the Epac1 knockout phenotype. ESI-09 treatment dramatically decreases the morbidity and mortality associated with fatal spotted fever rickettsiosis. Our results demonstrate that Epac1-mediated signaling represents a mechanism for host-pathogen interactions and that Epac1 is a potential target for the prevention and treatment of fatal rickettsioses.Entities:
Keywords: Epac inhibitor; cyclic AMP; prophylaxis; rickettsial infection; therapeutics
Mesh:
Substances:
Year: 2013 PMID: 24218580 PMCID: PMC3845138 DOI: 10.1073/pnas.1314400110
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205